Category: Cognate BioServices; Cobra Biologics

– Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products – EW Healthcare Partners and its co-investors provide the financing for the transaction MEMPHIS, Tennessee, Nov. 4, 2019 /PRNewswire/ — Cognate BioServices (Cognate), a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products […] … Read MoreCognate BioServices announces acquisition of Cobra Biologics